Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

The improved cure fraction for esophageal cancer in Linzhou city

Authors: Shuzheng Liu, Lanwei Guo, Qiong Chen, Liang Yu, Bianyun Li, Xiaoqin Cao, Xibin Sun

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximate disease-specific survival. However, the cure fraction maybe great interest to patients and physicians. This study aimed to investigate the cure fraction of esophageal cancer in Linzou city during 2003–2012 with a cure model.

Methods

We carried out a population-based study of 8067 esophageal cancer patients in the Linzhou city during 2003–2012. Flexible parametric cure models were used to estimate cure proportions and median survival times of uncured by year of diagnosed and age. In each model, an interaction between calendar year and age were included. All variables in the model were included both as constant and time-varying effects.

Results

The 5-year relative survival rate was increased in every age group from 2003 to 2012. The huge increase in the cure proportion was observed in each age group. At the year of 2011–2012, 79.8%, 58.0%, 123.4% and 162.7% improvements of cure proportion were seen in age group 19–49, 50–59, 60–69 and 70–99 years compared with year of 2003–2004. Meanwhile, survival of ‘uncured’ patients changed little in all age group.

Conclusions

The improvement of survival in Linzhou city during 2003–2012 was mainly due to an increasing cure proportion. Huge improvement of cure fraction within short period is likely due to the organized screening of esophageal cancer in Linzhou city.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRef
2.
go back to reference Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, Yang Z, Zou X, He J. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.CrossRef Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, Yang Z, Zou X, He J. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.CrossRef
3.
go back to reference Chen W, Zheng R, Zhang S, Zeng H, Zuo T, Xia C, Yang Z, He J. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res. 2017;29(1):1–10.CrossRef Chen W, Zheng R, Zhang S, Zeng H, Zuo T, Xia C, Yang Z, He J. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res. 2017;29(1):1–10.CrossRef
4.
go back to reference Ma YT, Lian SY, Liu ZC, Cheng LP, Li BY, Quan PL, Lu JB, Sun XB. Period survival analysis of esophageal cancer in Linzhou city of Henan province. Zhonghua Yu Fang Yi Xue Za Zhi. 2009;43(12):1100–4.PubMed Ma YT, Lian SY, Liu ZC, Cheng LP, Li BY, Quan PL, Lu JB, Sun XB. Period survival analysis of esophageal cancer in Linzhou city of Henan province. Zhonghua Yu Fang Yi Xue Za Zhi. 2009;43(12):1100–4.PubMed
5.
go back to reference Liu SZ, Yu L, Chen Q, Quan PL, Cao XQ, Sun XB. Incidence and survival of esophageal cancer with different histological types in Linzhou between 2003 and 2012. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(5):393–7.PubMed Liu SZ, Yu L, Chen Q, Quan PL, Cao XQ, Sun XB. Incidence and survival of esophageal cancer with different histological types in Linzhou between 2003 and 2012. Zhonghua Yu Fang Yi Xue Za Zhi. 2017;51(5):393–7.PubMed
6.
go back to reference Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L, Tang J, Chen J, Wei K, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015;136(8):1921–30.CrossRef Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L, Tang J, Chen J, Wei K, et al. Cancer survival in China, 2003-2005: a population-based study. Int J Cancer. 2015;136(8):1921–30.CrossRef
7.
go back to reference Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260(2):103–17.CrossRef Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260(2):103–17.CrossRef
8.
go back to reference Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51–64.CrossRef Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51–64.CrossRef
9.
go back to reference Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F. The cure for colon cancer: results from the EUROCARE study. Int J Cancer. 1998;77(3):322–9.CrossRef Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F. The cure for colon cancer: results from the EUROCARE study. Int J Cancer. 1998;77(3):322–9.CrossRef
10.
go back to reference Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011;11:96.CrossRef Andersson TM, Dickman PW, Eloranta S, Lambert PC. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol. 2011;11:96.CrossRef
11.
go back to reference Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175–97.CrossRef Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175–97.CrossRef
12.
go back to reference Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8(3):576–94.CrossRef Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics. 2007;8(3):576–94.CrossRef
13.
go back to reference Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med. 2007;26(30):5486–98.CrossRef Nelson CP, Lambert PC, Squire IB, Jones DR. Flexible parametric models for relative survival, with application in coronary heart disease. Stat Med. 2007;26(30):5486–98.CrossRef
14.
go back to reference De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med. 1999;18(4):441–54.CrossRef De Angelis R, Capocaccia R, Hakulinen T, Soderman B, Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med. 1999;18(4):441–54.CrossRef
15.
go back to reference Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551–61.CrossRef Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8(5):551–61.CrossRef
16.
go back to reference Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations: methodological note no 10. Bethesda: National Cancer Institute; 1959. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations: methodological note no 10. Bethesda: National Cancer Institute; 1959.
17.
go back to reference Andersson TML, Lambert PC. Fitting and modeling cure in population-based cancer studies within the framework of flexible parametric survival models. Stata J. 2012;12(4):623–38. Andersson TML, Lambert PC. Fitting and modeling cure in population-based cancer studies within the framework of flexible parametric survival models. Stata J. 2012;12(4):623–38.
18.
go back to reference Lambert PC, Dickman PW, Osterlund P, Andersson T, Sankila R, Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer registry. Int J Cancer. 2007;121(9):2052–9.CrossRef Lambert PC, Dickman PW, Osterlund P, Andersson T, Sankila R, Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer registry. Int J Cancer. 2007;121(9):2052–9.CrossRef
19.
go back to reference liu ZC, Lian SY, Li BY. An analysis of gastric cardiac/esophageal lesions diagnosed by endoscope examination in esophageal cancer high risk area in Linzhou. China Cancer. 2014;23(2):124–7. liu ZC, Lian SY, Li BY. An analysis of gastric cardiac/esophageal lesions diagnosed by endoscope examination in esophageal cancer high risk area in Linzhou. China Cancer. 2014;23(2):124–7.
20.
go back to reference Guan CT, Song GH, Li BY, Gong YW, Hao CQ, Xue LY, Chen WQ, Wei WQ. Endoscopy screening effect on stage distributions of esophageal cancer: a cluster randomized cohort study in China. Cancer Sci. 2018;109(6):1995–2002.CrossRef Guan CT, Song GH, Li BY, Gong YW, Hao CQ, Xue LY, Chen WQ, Wei WQ. Endoscopy screening effect on stage distributions of esophageal cancer: a cluster randomized cohort study in China. Cancer Sci. 2018;109(6):1995–2002.CrossRef
21.
go back to reference Liu SZ, Yu L, Li BY, Hao CQ, Wang JW, Cao XQ, Sun XB. Analysis survival of screening and non-screening patients of esophageal cancer in Linzhou city. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(3):238–42.PubMed Liu SZ, Yu L, Li BY, Hao CQ, Wang JW, Cao XQ, Sun XB. Analysis survival of screening and non-screening patients of esophageal cancer in Linzhou city. Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52(3):238–42.PubMed
22.
go back to reference Lambert PC, Dickman PW, Weston CL, Thompson JR. Estimating the cure fraction in population-based cancer studies by using finite mixture models. J R Stat Soc: Ser C: Appl Stat. 2010;59(1):35–55.CrossRef Lambert PC, Dickman PW, Weston CL, Thompson JR. Estimating the cure fraction in population-based cancer studies by using finite mixture models. J R Stat Soc: Ser C: Appl Stat. 2010;59(1):35–55.CrossRef
Metadata
Title
The improved cure fraction for esophageal cancer in Linzhou city
Authors
Shuzheng Liu
Lanwei Guo
Qiong Chen
Liang Yu
Bianyun Li
Xiaoqin Cao
Xibin Sun
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4867-7

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine